Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MITF inhibitors(melanocyte inducing transcription factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H12N2O4S |
InChIKeyCSYFFQVEQXEIAB-UHFFFAOYSA-N |
CAS Registry19992-50-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 18 Sep 2014 |